Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

New ET antagonists from Merck KGaA bearing a benzothiadiazole functionality

Jan. 27, 1998

U.K. launch for Posicor

Jan. 27, 1998

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

Jan. 27, 1998

Takeda discloses compounds that upregulate LDL receptors

Jan. 27, 1998

Adenosine metabolism inhibitor research at Cypros supported by grant

Jan. 26, 1998

Atherosclerosis program at Genome Therapeutics expanded

Jan. 26, 1998

Two NDAs up for review this week by Cardiovascular and Renal Drugs Advisory Committee

Jan. 26, 1998

T Cell Sciences awarded SBIR grant for atherosclerosis vaccine

Jan. 23, 1998

SmithKline Beecham presents new azetidinones for atherosclerosis

Jan. 23, 1998

Japan Energy describes inhibitors of SMC proliferation

Jan. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...